The Role of Urotensin-II in Obesity and Metabolic Syndrome in Pediatric Population
Background: Urotensin-II (U-II) is a short cyclic peptide that is widely recognized as one of the most potent vasoconstrictors. U-II plays a role in the pathophysiology of MS, participating in the development of essential hypertension, insulin resistance, hyperglycemia, and a proinflammatory state....
Main Authors: | Marko Simunovic, Andrija Jukic, Martina Paradzik, Daniela Supe-Domic, Lada Stanisic, Marina Degoricija, Anna Hummelvoll Hillestad, Veselin Skrabic, Josko Bozic |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-02-01
|
Series: | Children |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9067/9/2/204 |
Similar Items
-
Urotensin II system in chronic kidney disease
by: Olugbenga S. Michael, et al.
Published: (2024-01-01) -
Serum Urotensin II Levels Are Elevated in Patients with Obstructive Sleep Apnea
by: Ante Mihovilovic, et al.
Published: (2023-05-01) -
Urotensin-II, oxidative stress, and inflammation increase in hypertensive and resistant hypertensive patients
by: Eray Metin Guler, et al.
Published: (2021-04-01) -
Expressions of irisin and urotensin II and their relationships with blood pressure in patients with preeclampsia
by: Li-Jie Zhang, et al.
Published: (2017-07-01) -
Combination of Docking-Based and Pharmacophore-Based Virtual Screening Identifies Novel Agonists That Target the Urotensin Receptor
by: Na Li, et al.
Published: (2022-12-01)